Envudeucitinib, a tyrosine kinase 2 (TYK2) inhibitor, demonstrated rapid improvement and progressively deepening skin ...

UT Southwestern Medical Center researchers have identified how the quintessential immune protein known as stimulator of ...

Brepocitinib significantly boosts global, all secondary dermatomyositis scores in VALOR tr ...

Many people with an aggressive blood cancer called diffuse large B cell lymphoma are cured by the current gold standard of ...

Learn what the Nipah virus is, how it spreads, and why it has one of the highest fatality rates among infectious diseases.

Growth potential is driven by increased biopharmaceutical demand, chronic disease prevalence, and regional market expansion, especially in Asia-PacificDublin, April 01, 2026 (GLOBE NEWSWIRE) -- The ...

Conditional approval of intravesical gene therapy was supported by clinical evidence showing a 53.4% complete response rate in patients with treatment-resistant non-muscle-invasive bladder cancer.

HIV exhausts the body's immune system by overactivating it, despite effective antiviral treatment. Researchers from Linköping ...

Astellas Pharma has become the latest company to pull back from a potential treatment for Sjögren’s syndrome, an autoimmune ...

A first-in-class monoclonal antibody has shown significant reductions in skin disease in patients with cutaneous lupus erythematosus (CLE). Litifilimab met the primary endpoint of reduction of disease ...